Parexel Insights

Browse the Blog

Actions Required Now for EUAs as the U.S. Public Health Emergency Ends in May

03.09.23 - 3 min - On May 11, 2023, the public health emergency (PHE) is anticipated to officially end, and with it, this extraordinary use of EUA. Is your organization prepared?

Regulatory Consulting leader re-joins Parexel to provide expertise in Asia/Pacific

02.09.23 - 2 min - Mingping Zhang brings expertise in biotech and cell and gene therapy to develop new drugs for patients

Parexel’s Deb Pasko shares her personal rare disease story in honor of Rare Disease Day

02.09.23 - 6 min - Hello, my name is Deb Pasko, and I am a RWD Solutions Director within the Scientific Data Organization at Parexel. I have Ehlers-Danlos syndrome, hypermobility type, known as hEDS.

New Real World Evidence leader in Asia/Pacific returns to Parexel with lessons learned from China adventure

01.13.23 - 3 min - Sheng Feng re-joins Parexel to drive RWE offering and consulting services in Asia/Pacific

The New Frontier of Innovative Therapies: Navigating What's Next

01.12.23 - 6 min - Recent advances in cell and gene therapy research reflect a promising path forward for curative treatments in new therapeutic areas, with the following milestones leading the way...

Load more

News Highlights

EQT Private Equity and Goldman Sachs Asset Management Complete Acquisition of Parexel

Parexel and Kyoto University Hospital Announce Strategic Alliance

Parexel Strengthens Clinical Data and Digital Services Offering with Key Appointment

View all blogs

We are always available for a conversation.

*